ClinicalTrials.Veeva

Menu

Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis (MMT)

G

Ghent University Hospital (UZ)

Status

Completed

Conditions

Peritoneal Carcinomatosis

Treatments

Procedure: Sampling peritoneal tissue

Study type

Observational

Funder types

Other

Identifiers

NCT03777943
EC/2017/0784

Details and patient eligibility

About

The goal of this project is to investigate the extent and role of mesothelial - mesenchymal transition (MMT) and cancer associated fibroblasts (CAFs) in the pathogenesis of colorectal peritoneal carcinomatosis (PC).

Enrollment

53 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Patients presenting with colorectal peritoneal carcinomatosis

Exclusion criteria

  • Pregnancy or breast feeding
  • Psychiatric pathology capable of affecting comprehension and judgment faculty
  • HIPEC (hyperthermic intraperitoneal chemotherapy) or PIPAC (pressurized intraperitoneal aerosol chemotherapy) in the past
  • Abdominal radiation treatment

Trial design

53 participants in 1 patient group

Cytoreductive surgery (CRS)
Description:
In patients presenting with colorectal peritoneal carcinomatosis, peritoneal tissue will be sampled during surgery at 4 different locations.
Treatment:
Procedure: Sampling peritoneal tissue

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems